# Bioavailability of Different n-3 Fatty Acid Formulations

> **NCT01214278** · PHASE4 · COMPLETED · sponsor: **Gottfried Wilhelm Leibniz Universität Hannover** · enrollment: 12 (actual)

## Conditions studied

- Health

## Interventions

- **DRUG:** rTG
- **DRUG:** GArTG
- **DRUG:** EE
- **DRUG:** KPL

## Key facts

- **NCT ID:** NCT01214278
- **Lead sponsor:** Gottfried Wilhelm Leibniz Universität Hannover
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2011-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01214278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01214278, "Bioavailability of Different n-3 Fatty Acid Formulations". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01214278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*